NCT00423462

Brief Summary

Analysis of the ongoing patient-therapist interaction, the transference, is considered a key active ingredient in psychoanalytically oriented psychotherapy and psychoanalysis.However, one century after Sigmund Freuds's famous "Dora" case, the first clinical description of transference, no study of transference interpretations have been published.In the present study 100 out-patients were randomized to receive one year weekly dynamic psychotherapy, with and without transference interpretations. That is, one treatment component,transference interpretations, were added to a comparison condition, therapy of the same format, by the same therapists, but without use of transference interpretation. All treatment session were audiotaped, and treatment integrity have been carefully checked. Patients were evaluated at treatment termination, one year after treatment termination and three years after treatment termination. Enrollment of patients started january 1993, and all follow-up evaluations completed by December 2005.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jan 1993

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 1993

Completed
12.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2005

Completed
1.1 years until next milestone

First Submitted

Initial submission to the registry

January 16, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

January 18, 2007

Completed
Last Updated

August 27, 2007

Status Verified

August 1, 2007

First QC Date

January 16, 2007

Last Update Submit

August 24, 2007

Conditions

Keywords

PsychotherapyLong-term effects

Outcome Measures

Primary Outcomes (2)

  • The Psychodynamic Functioning Scales (PFS), clinician rated

  • Inventory if Interpersonal Problems-Circumplex version (IIP-C), self-report

Secondary Outcomes (2)

  • The Global Assessment of Functioning Scale (GAF)

  • Global Severity Index (GSI) from SCL-90-R

Interventions

Eligibility Criteria

Age20 Years - 60 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Age 20 - 60 years
  • Diagnoses Mood-disorder, non-psychotic
  • Anxiety disorders
  • Personality disorders
  • Interpersonal problems not due to a mental disorder

You may not qualify if:

  • Psychotic disorders
  • Bipolar disorder
  • Organic brain disorder
  • Substance abuse
  • Long-term (years) disability
  • Mental retardation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Department of Psychiatry, Faculty of Medicine, University of Oslo

Oslo, 0881 Oslo, Norway

Location

Related Publications (11)

  • Hoglend P, Amlo S, Marble A, Bogwald KP, Sorbye O, Sjaastad MC, Heyerdahl O. Analysis of the patient-therapist relationship in dynamic psychotherapy: an experimental study of transference interpretations. Am J Psychiatry. 2006 Oct;163(10):1739-46. doi: 10.1176/ajp.2006.163.10.1739.

  • Nissen-Lie HA, Dahl HJ, Hoglend PA. Patient factors predict therapists' emotional countertransference differently depending on whether therapists use transference work in psychodynamic therapy. Psychother Res. 2022 Jan;32(1):3-15. doi: 10.1080/10503307.2020.1762947. Epub 2020 May 13.

  • Tallberg P, Ulberg R, Johnsen Dahl HS, Hoglend PA. Core conflictual relationship theme: the reliability of a simplified scoring procedure. BMC Psychiatry. 2020 Apr 6;20(1):150. doi: 10.1186/s12888-020-02558-4.

  • Sorbye O, Dahl HJ, Eells TD, Amlo S, Hersoug AG, Haukvik UK, Hartberg CB, Hoglend PA, Ulberg R. Psychodynamic case formulations without technical language: a reliability study. BMC Psychol. 2019 Oct 24;7(1):67. doi: 10.1186/s40359-019-0337-5.

  • Ulberg R, Ness E, Dahl HS, Hoglend PA, Critchfield K, Blayvas P, Amlo S. Relational interventions in psychotherapy: development of a therapy process rating scale. BMC Psychiatry. 2016 Sep 6;16(1):310. doi: 10.1186/s12888-016-1021-4.

  • Ulberg R, Amlo S, Hoglend P. Manual for Transference Work Scale; a micro-analytical tool for therapy process analyses. BMC Psychiatry. 2014 Nov 18;14:291. doi: 10.1186/s12888-014-0291-y.

  • Ulberg R, Amlo S, Hersoug AG, Dahl HS, Hoglend P. The effects of the therapist's disengaged feelings on the in-session process in psychodynamic psychotherapy. J Clin Psychol. 2014 May;70(5):440-51. doi: 10.1002/jclp.22088. Epub 2014 Mar 27.

  • Ulberg R, Hoglend P, Marble A, Johansson P. Women respond more favorably to transference intervention than men: a randomized study of long-term effects. J Nerv Ment Dis. 2012 Mar;200(3):223-9. doi: 10.1097/NMD.0b013e318247cb6d.

  • Hoglend P, Hersoug AG, Bogwald KP, Amlo S, Marble A, Sorbye O, Rossberg JI, Ulberg R, Gabbard GO, Crits-Christoph P. Effects of transference work in the context of therapeutic alliance and quality of object relations. J Consult Clin Psychol. 2011 Oct;79(5):697-706. doi: 10.1037/a0024863.

  • Ulberg R, Hoglend P, Marble A, Sorbye O. From submission to autonomy: approaching independent decision making. A single-case study in a randomized, controlled study of long-term effects of dynamic psychotherapy. Am J Psychother. 2009;63(3):227-43. doi: 10.1176/appi.psychotherapy.2009.63.3.227.

  • Ulberg R, Johansson P, Marble A, Hoglend P. Patient sex as moderator of effects of transference interpretation in a randomized controlled study of dynamic psychotherapy. Can J Psychiatry. 2009 Feb;54(2):78-86. doi: 10.1177/070674370905400205.

MeSH Terms

Conditions

Mood DisordersAnxiety DisordersPersonality Disorders

Condition Hierarchy (Ancestors)

Mental Disorders

Study Officials

  • Per Høglend, M.D. Ph. D.

    Department of Psychiatry, Faculty of Medicine, Unoversity of Oslo

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
SINGLE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER

Study Record Dates

First Submitted

January 16, 2007

First Posted

January 18, 2007

Study Start

January 1, 1993

Study Completion

December 1, 2005

Last Updated

August 27, 2007

Record last verified: 2007-08

Locations